Suzan Ber

ORCID: 0000-0003-4219-6032
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Cell Image Analysis Techniques
  • 3D Printing in Biomedical Research
  • Mathematical Biology Tumor Growth
  • Pluripotent Stem Cells Research
  • Advanced Fluorescence Microscopy Techniques
  • Bone Tissue Engineering Materials
  • Microtubule and mitosis dynamics
  • Radiopharmaceutical Chemistry and Applications
  • Advanced Biosensing Techniques and Applications
  • biodegradable polymer synthesis and properties
  • bioluminescence and chemiluminescence research
  • Protein Degradation and Inhibitors
  • Congenital heart defects research
  • Cancer-related Molecular Pathways
  • Cancer, Hypoxia, and Metabolism
  • Biochemical and Molecular Research
  • Collagen: Extraction and Characterization
  • Ferroptosis and cancer prognosis
  • Dental Implant Techniques and Outcomes
  • Nanoparticle-Based Drug Delivery
  • Viral Infectious Diseases and Gene Expression in Insects
  • DNA Repair Mechanisms
  • Periodontal Regeneration and Treatments
  • Career Development and Diversity

Babraham Institute
2024

University of Cambridge
2014-2019

MRC Cancer Unit
2019

Medical Research Council
2014-2018

Hutchison/MRC Research Centre
2013-2017

The Gurdon Institute
2012

Wellcome Trust
2012

Middle East Technical University
2002-2004

Abstract Glioblastoma, the most common and aggressive adult brain tumor, is characterized by extreme phenotypic diversity treatment failure. Through fluorescence-guided resection, we identified fluorescent tissue in sub-ependymal zone (SEZ) of patients with glioblastoma. Histologic analysis genomic characterization revealed that SEZ harbors malignant cells tumor-initiating capacity, analogous to isolated from tumor mass (T). We observed resistance supramaximal chemotherapy doses along...

10.1158/0008-5472.can-13-3131 article EN Cancer Research 2014-11-19

The G2 checkpoint monitors DNA damage, preventing mitotic entry until the damage can be resolved. mechanisms controlling recovery are unclear. Here, we identify non-genetic heterogeneity in fidelity and timing of damage-induced enforcement individual cells from same population. Single-cell fluorescence imaging reveals that damaged experience varying durations arrest, recover with levels remaining signal or damage. A gating mechanism dependent on polo-like kinase-1 (PLK1) activity underlies...

10.1038/ncomms5048 article EN cc-by-nc-nd Nature Communications 2014-06-04

Mutations activating KRAS underlie many forms of cancer, but are refractory to therapeutic targeting. Here, we develop Poloppin, an inhibitor protein-protein interactions via the Polo-box domain (PBD) mitotic Polo-like kinases (PLKs), in monotherapeutic and combination strategies target mutant KRAS. Poloppin engages its targets biochemical cellular assays, triggering arrest with defective chromosome congression. kills cells expressing KRAS, selectively enhancing death mitosis. PLK1 or PLK4...

10.1016/j.chembiol.2017.07.009 article EN cc-by Cell chemical biology 2017-08-01

Fluorescence lifetime sensing enables researchers to probe the physicochemical environment of a fluorophore providing window through which we can observe complex molecular make-up cell. imaging microscopy (FLIM) quantifies and maps cell biochemistry, ensemble dynamic processes. Unfortunately, typical high-resolution FLIM systems exhibit rather limited acquisition speeds, often insufficient capture time evolution biochemical processes in living cells. Here, describe theoretical background...

10.1088/2050-6120/ab3bd2 article EN cc-by Methods and Applications in Fluorescence 2019-08-19

Abstract Glioblastoma (GB), the most common and aggressive adult brain tumor, is characterized by phenotypic diversity ultimately treatment failure. Using fluorescence-guided sampling we integrated copy number aberration, gene expression molecular clock data to show that sub-ependymal zone (SEZ) contains precursor cells of corresponding mass. The genetically distinct tumor margin non self-renewing retain potential regenerate tumor. Functional assays confirmed SEZ marginal disease were less...

10.1158/1538-7445.am2013-5016 article EN Cancer Research 2013-04-01

Tissue-specific stem cells are considered to have a limited differentiation potential. Recently, this notion was challenged by reports that showed broader potential of neural cells, in vitro and vivo, although the molecular mechanisms regulate plasticity unknown. Here, we report derived from mouse embryonic cortex respond Lif serum undergo epithelial mesenchymal transition (EMT)-mediated dedifferentiation process within 48 h, together with transient upregulation pluripotency markers and,...

10.1371/journal.pone.0030759 article EN cc-by PLoS ONE 2012-01-20

The biochemical activities underlying cell-fate decisions vary profoundly even in genetically identical cells. But such non-genetic heterogeneity remains refractory to current imaging methods, because their capacity monitor multiple single living cells over time limited 1 . Here, we deploy a family of newly designed GFP-like sensors (NyxBits) with fast photon-counting electronics and bespoke analytics (NyxSense) multiplexed imaging, define network determining the fate exposed DNA-damaging...

10.1101/427237 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2018-10-02

SUMMARY Mutations in KRAS, particularly at codon 12, are frequent adenocarcinomas of the colon, lungs and pancreas, driving carcinogenesis by altering cell signalling reprogramming metabolism. However, specific mechanisms which different KRAS G12 alleles initiate distinctive patterns metabolic is unclear. Using isogenic panels colorectal lines harbouring G12A, G12C, G12D G12V heterozygous mutations employing transcriptomics, metabolomics, extensive biochemical validation, we demonstrate...

10.1101/2024.10.19.618135 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-10-22

<div>Abstract<p>Glioblastoma, the most common and aggressive adult brain tumor, is characterized by extreme phenotypic diversity treatment failure. Through fluorescence-guided resection, we identified fluorescent tissue in sub-ependymal zone (SEZ) of patients with glioblastoma. Histologic analysis genomic characterization revealed that SEZ harbors malignant cells tumor-initiating capacity, analogous to isolated from tumor mass (T). We observed resistance supramaximal chemotherapy...

10.1158/0008-5472.c.6505922 preprint EN 2023-03-30

<p>Supplementary experimental procedures: this file contains an expanded materials and methods section on 5-ALA administration sample collection, cell lines propagation, immunofluorescence in vivo assays, genomic molecular clock analysis, fluorescence situ hybridization, drug concentration used the proliferation assay MGMT promoter methylation analysis. Supplementary Figure S1: figure illustrates identification of sub-ependymal zone (SEZ) two GB patients included study. S2: shows...

10.1158/0008-5472.22401800 preprint EN cc-by 2023-03-30

<p>Supplementary experimental procedures: this file contains an expanded materials and methods section on 5-ALA administration sample collection, cell lines propagation, immunofluorescence in vivo assays, genomic molecular clock analysis, fluorescence situ hybridization, drug concentration used the proliferation assay MGMT promoter methylation analysis. Supplementary Figure S1: figure illustrates identification of sub-ependymal zone (SEZ) two GB patients included study. S2: shows...

10.1158/0008-5472.22401800.v1 preprint EN cc-by 2023-03-30

<div>Abstract<p>Glioblastoma, the most common and aggressive adult brain tumor, is characterized by extreme phenotypic diversity treatment failure. Through fluorescence-guided resection, we identified fluorescent tissue in sub-ependymal zone (SEZ) of patients with glioblastoma. Histologic analysis genomic characterization revealed that SEZ harbors malignant cells tumor-initiating capacity, analogous to isolated from tumor mass (T). We observed resistance supramaximal chemotherapy...

10.1158/0008-5472.c.6505922.v1 preprint EN 2023-03-30
Coming Soon ...